| Patents for C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups (57,272) |
|---|
| 05/12/2009 | US7531536 Inhibitors of glycogen synthase kinase-3 (gsk-3) and aurora-2, both serine/threonine protein kinases; for treating diseases such as cancer, diabetes and alzheimer's disease |
| 05/12/2009 | US7531532 Pyridine derivative and pyrimidine derivative |
| 05/12/2009 | US7531531 Method of treating diseases associated with altered kinase activity with bicyclo-pyrazoles |
| 05/12/2009 | US7531530 derivatives of tricyclic lactam indoles and tricyclic lactam benzimidazoles; poly (ADP-ribose) polymerase (PARP) inhibitors; breast cancer, cancers caused by genetic defect in a gene; side effects reduction by not administering as a combination therapy; low doses; antiapoptosis; BRCA1 or BRCA2 expression |
| 05/12/2009 | US7531320 Modulation of β-catenin/TCF-activated transcription |
| 05/12/2009 | CA2546987C 5,7-diaminopyrazolo [4,3-d] pyrimidines with pde-5 inhibiting activity |
| 05/12/2009 | CA2517933C Novel fused heteroaromatic compounds as transforming growth factor (tgf) inhibitors |
| 05/12/2009 | CA2264005C Piperazino derivatives as neurokinin antagonists |
| 05/07/2009 | WO2009058810A1 Process for the preparation of substituted 2,4,5,6,7,8-hexahydro-1,2,6-triaza-azulene derivatives |
| 05/07/2009 | WO2009056692A2 Novel 6-triazolopyridazinesulfanyl benzothiazole and benzimidazole derivatives, method for production thereof and application as medicaments and pharmaceutical compositions and novel use as met inhibitors |
| 05/07/2009 | WO2009056626A1 Use of halogenated phthalocyanines |
| 05/07/2009 | WO2009056077A2 A new method of manufacturing 2-(6-(4-chlorophenyl)-2,2-dimethyl-7-phenyl-2,3-dihydro-lh-pyrrolizine-5-yl)acetic acid (licofelone) |
| 05/07/2009 | WO2009056029A1 Purification method of pemetrexed salts,sodium salts and disodium salts |
| 05/07/2009 | WO2009006389A3 Pyrimidine derivatives useful as raf kinase inhibitors |
| 05/07/2009 | US20090118502 organic or inorganic salt of N-{3-[4'-(4-Aminomethyl-[1,2,3]triazol-1-ylmethyl)-2-fluoro-biphenyl- 4-yl]-2-oxo-oxazolidin-5-(S)-ylmethyl}-acetamide; anti-infective, anti-proliferative, anti-inflammatory, and prokinetic agents |
| 05/07/2009 | US20090118499 6,6-Bicyclic Ring Substituted Heterobicyclic Protein Kinase Inhibitors |
| 05/07/2009 | US20090118496 Crystallization Method for Intermediates of Carbapenem Antibiotics |
| 05/07/2009 | US20090118311 DHFR Enzyme Inhibitors |
| 05/07/2009 | US20090118292 Cytokine inhibitors |
| 05/07/2009 | US20090118277 3 Unsubstituted N-(aryl- or heteroaryl)-pyrazolo[1,5-a]pyrimidines as Kinase Inhibitors |
| 05/07/2009 | US20090118276 Thienopyrimidines, thienopyridines, and pyrrolopyrimidines as b-raf inhibitors |
| 05/07/2009 | US20090118273 Compounds and Compositions as Protein Kinase Inhibitors |
| 05/07/2009 | US20090118260 Aryl- and heteroaryl-substituted tetrahydrobenzazepines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin |
| 05/07/2009 | US20090118232 Indoles, 1h-indazoles, 1,2-benzisoxazoles, 1,2-benzoisothiazoles, and preparation and uses thereof |
| 05/07/2009 | US20090117125 Synthesis of 8h-3a-aza-cyclopenta[a]indenes and 5,10-dihydropyrrolo[1,2-b]isoquinolines derivatives and their use as antitumor therapeutic agents |
| 05/07/2009 | DE102007051762A1 Substituierte Pyrrolotriazine und ihre Verwendung Substituted Pyrrolotriazine and their use |
| 05/07/2009 | CA2695628A1 Novel 6-triazolopyridazinesulfanyl benzothiazole and benzimidazole derivatives, method for production thereof and application as medicaments and pharmaceutical compositions and novel use as met inhibitors |
| 05/06/2009 | EP2055705A1 Compound having cyclic group bound thereto through spiro binding and use thereof |
| 05/06/2009 | EP2054416A1 Substituted pyrazolopyrimidines, a process for their preparation and their use as medicine |
| 05/06/2009 | EP2054414A2 Imidazole amines as inhibitors of beta-secretase |
| 05/06/2009 | EP2054060A1 Fluorinated ligands for targeting peripheral benzodiazepine receptors |
| 05/06/2009 | EP1704154B1 Novel indeno [2,1a]indenes and isoindol [2,1-a]indoles |
| 05/06/2009 | EP1326865B1 Aza- and polyaza-naphthalenyl carboxamides useful as hiv integrase inhibitors |
| 05/06/2009 | CN101426794A Methods for preparing eszopiclone crystalline form A, substantially pure eszopiclone and optically enriched eszopiclone |
| 05/06/2009 | CN101426793A Methods for the preparation of hcv polymerase inhibitors |
| 05/06/2009 | CN101426792A Pyrazolopyrimidines as therapeutic agents |
| 05/06/2009 | CN101426771A Process for manufacturing diazepine derivatives |
| 05/06/2009 | CN101426486A Compounds for the treatment of inflammatory disorders and microbial diseases |
| 05/06/2009 | CN101423524A Diglutamate derivates and application thereof in preparation of pemetrexed |
| 05/06/2009 | CN101423518A Imidazole derivates and medical use thereof |
| 05/06/2009 | CN100484938C Method for preparing ketorolac tromethamine |
| 05/05/2009 | US7528140 Substituted pyrrolo[3,2-d]pyrimidines as glycogen synthase kinase (GSK) inhibitors |
| 05/05/2009 | US7528138 Pyrazolo[1,5-a]pyrimidines useful as inhibitors of protein kinases |
| 05/05/2009 | US7528136 Prolinamide derivatives as NK3 antagonists |
| 05/05/2009 | US7528127 Short-acting benzodiazepines |
| 05/05/2009 | CA2448281C Optical resolution of (1-benzyl-4-methylpiperidin-3-yl)-methylamine and the use thereof for the preparation of pyrrolo 2,3-pyrimidine derivatives as protein kinases inhibitors |
| 05/05/2009 | CA2149298C Flk-1 is a receptor for vascular endothelial growth factor |
| 04/30/2009 | WO2009055674A1 Pyrrolopyrimidine alkynyl compounds and methods of making and using same |
| 04/30/2009 | WO2009055331A2 Bicyclic heterocycle derivatives and their use as modulators of the activity of gpr119 |
| 04/30/2009 | WO2009054984A1 Heterocycle phenyl amide t-type calcium channel antagonists |
| 04/30/2009 | WO2009054332A1 Pyridone-substituted-dihydropyrazolopyrimidinone derivative |
| 04/30/2009 | WO2009021169A3 (7h-pyrr0l0 [2, 3-d] pyrimidin-4-yl) -piperazines as kinase inhibitors for the treatment of cancer and inflammation |
| 04/30/2009 | WO2008138889A3 3, 6-disubstituted-imidazo [1, 2-b] pyridazines and 3, 5-disubstituted pyrazolo[1, 5-a] pyrimidines as phosphatidylinositol-3-kinase inhibitors |
| 04/30/2009 | WO2007064841A3 Porphyrinic compounds for use in flow cytometry |
| 04/30/2009 | WO2007001818A3 Substituted isoindole-1,3-diones |
| 04/30/2009 | WO2006105516A3 Compositions and methods for diagnosing and treating neuropsychiatric disorders |
| 04/30/2009 | US20090111982 Macrocyclic compounds as inhibitors of viral replication |
| 04/30/2009 | US20090111848 Halogenated Pyrazolo[1,5-A]Pyrimidines, Processes, Uses, Compositions and Intermediates |
| 04/30/2009 | US20090111805 Bicyclic heteroaromatic derivatives useful as anticancer agents |
| 04/30/2009 | US20090111794 Aryl-substituted bridged or fused diamines as modulators of leukotriene A4 hydrolase |
| 04/30/2009 | US20090111183 Ketone Ligands for Modulating the Expression of Exogenous Genes Via An Ecdysone Receptor Complex |
| 04/30/2009 | US20090110662 Modification of biological targeting groups for the treatment of cancer |
| 04/30/2009 | CA2703489A1 Pyridone-substituted-dihydropyrazolopyrimidinone derivative |
| 04/30/2009 | CA2703203A1 Bicyclic heterocycle derivatives and methods of use thereof |
| 04/30/2009 | CA2701594A1 Heterocycle phenyl amide t-type calcium channel antagonists |
| 04/29/2009 | EP2051980A1 Pyrrolotriazine kinase inhibitors |
| 04/29/2009 | EP2051715A2 Modulators of muscarinic receptors |
| 04/29/2009 | EP1861405B1 Method of reducing alpha, beta- unsaturated ketones in opioid compositions |
| 04/29/2009 | EP1771421B1 N-hydroxyamide derivatives and use thereof |
| 04/29/2009 | EP1542994B1 Novel oxazole compounds as transforming growth factor (tgf) inhibitor |
| 04/29/2009 | EP1539764B1 Aryl-substituted diazabicycloalkanes as nicotinic acetylcholine agonists. |
| 04/29/2009 | EP1066286B1 Heterocyclo-substituted imidazopyrazine protein tyrosine kinase inhibitors |
| 04/29/2009 | CN101421272A 3-unsubstituted N-(aryl- or heteroarvl)-pyrazolori (1,5-a) pyrimidines as kinase inhibitors |
| 04/29/2009 | CN101421258A Sulfonyl-substituted bicyclic compounds as modulators of ppar |
| 04/29/2009 | CN101421236A Use of aryl- or alkyloxy-substituted phthalocyanines as marking substances for liquids |
| 04/29/2009 | CN101418002A Conjugated dendritic electrically-induced pure red material and preparation method and use thereof |
| 04/29/2009 | CN101418001A Dipeptidase-IV inhibitor sulfonyl urea derivates |
| 04/29/2009 | CN101418000A DPP-IV inhibitor derivates containing benzofuran sulfonyl ureas |
| 04/29/2009 | CN101417999A Piperazines derivates, preparation method thereof and application thereof in medicine |
| 04/29/2009 | CN101417998A Purification method of pemetrexed salt |
| 04/29/2009 | CN100482666C Hetaryl-substituted pyrazolidindione derivatives with pesticidal characteristics |
| 04/29/2009 | CN100482665C Pyrazolo 1,5-a pyrimidine derivatives |
| 04/29/2009 | CN100482664C 1,5-disubstituted-3,4-dihydro-1H-pyrimido [4,5-D] pyrimidi-2-one compounds and their use in treating CSBP/P38 kinase mediated diseases |
| 04/29/2009 | CN100482225C Novel heterocyclic compounds which are active as inhibitors of beta-lactamases |
| 04/28/2009 | US7524969 Cardiovascular disorders; anticancer agents; antidiabetic agents; dietetics |
| 04/28/2009 | US7524956 Hemisynthetic method and new compounds |
| 04/28/2009 | US7524875 Polyether with glycerol backbone; capable of being labeled |
| 04/28/2009 | US7524873 Substituted N-phenylmethyl ethanamines; N-((6-(methyloxy)-4'-(trifluoromethyl)-1,1'-biphenyl-3-yl)methyl)-1-(1-naphthalenyl)ethanamine; parathyroid hormone inhibitors; antisecretory agents; osteoporosis |
| 04/28/2009 | US7524862 Melanin-concentrating hormone (MCH); for the treatment of metabolic disorders and/or eating disorders, such as obesity and diabetes, also drug dependencies, and urinary incontinence |
| 04/28/2009 | US7524853 Cyclohexylthiophenepyrimidinone, cyclohexylpyrrolylpyrimidinone or cyclohexylfuranylpyrimidinone compounds for use in the treatment of a steroid hormone dependent diseases; inhibitor of 17 beta -hydroxysteroid dehydrogenase enzymes |
| 04/28/2009 | US7524852 Bicyclic pyrimidine derivatives |
| 04/28/2009 | US7524847 Inhibit Dipeptidyl peptidase-IV; 7-(2-Butynyl)-3-methyl-3,7-dihydropurine-2,6-dione; suppress degradation of Glucagon-Like Peptide-1; enhance action of incretin; facilitate insulin secretion from pancreatic beta -cells due to glucose stimulus; postchallenge hyperglycemia, improved oral glucose tolerance |
| 04/28/2009 | US7524845 Chemokine receptor 1 (CCR1) antagonists; 1-[4-phenylpiperazin-1-yl]-2-pyrazolo[4,3-b]pyridin-1-yl-ethanone compounds; inflammatory condition or autoimmune disorders such as rheumatoid arthritis, multiple sclerosis, transplant rejection, restenosis, dermatitis |
| 04/28/2009 | US7524843 N-methyl-N-(1-methyl-1H-indol-3-ylmethyl)-3-(7-oxo-5,6,7,8-tetrahydro-1,8-naphthyridin-3-yl)acrylamide as an enzyme inhibitor for both Fab I and Fab K which are used in the biosynthesis of fatty acids; enoyl-acyl-carrier protein renamed Fab 1; bactericides; fungicides; Staphylococcus aureus; antibiotics |
| 04/28/2009 | US7524841 4,4-disubstituted piperidine derivatives having CCR3 antagonism |
| 04/28/2009 | US7524840 Inhibit angiogenesis, kinase activity; cancer tumors; convert a benzodiazepine lactam to an O-methyl ether; react ether with dimethyl acetal of N,N-dimethyl acetamide; react with hydrazine; 5-(2-chlorophenyl)-1,2-dihydro-7-fluoro-8-(3-(4-morpholinyl)propoxy))-3-methyl-pyrazolo[3,4-b][1,4]benzodiazepine |
| 04/28/2009 | US7524839 Such as 1-phenylsulfonyl-4-piperazinylindole hydrochloride for treatment or prophylaxis of disease mediated by serotonin related receptor, obesity, and/or central nervous system disorder |
| 04/28/2009 | US7524838 Pyrazolyl derivatives, preparation process and intermediates of this process as medicinal products and pharmaceutical compositions containing them |
| 04/28/2009 | US7524821 Scaffolded maleimide clusters for multivalent peptide assembly |
| 04/28/2009 | US7524484 Delivery of diphenhydramine through an inhalation route |